Skip to content

F19.150

Billable

Other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions

Last updated: FY2026 ICD-10-CM (Oct 1, 2025 – Sep 30, 2026) | CMS-HCC V28 (100% phase-in, PY2026)

Is F19.150 an HCC code?

Yes. F19.150 maps to Drug/Alcohol Psychosis under the CMS-HCC V28 risk adjustment model (and Drug/Alcohol Psychosis under V24).

HCC Category Mapping

V28HCC 135Drug/Alcohol Psychosis
0.000
V24HCC 54Drug/Alcohol Psychosis
0.434
ESRDHCC 54Drug/Alcohol Psychosis
0.000

RAF weights shown are the community, non-dual, aged base weights from the CMS risk adjustment model file. Actual per-patient RAF contribution depends on member segment, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains in use during the transition and for historical data.

MEAT Criteria for F19.150

For F19.150 to count as a valid HCC diagnosis in a given encounter, the provider's documentation must show MEAT: Monitor, Evaluate, Assess, or Treat. A diagnosis from a prior year does not carry forward automatically — it has to be re-documented and supported each calendar year.

  • MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
  • EEvaluate: test results, medication response, or physical findings reviewed by the provider
  • AAssess: explicit mention in the assessment or plan with acknowledgment of status
  • TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis

Only one of M/E/A/T is required to support the code, but the documentation must be specific enough to show that the provider actually addressed F19.150 during that encounter — not just copy-forwarded from a problem list.

What This Code Means

F19.150 is the ICD-10-CM diagnosis code for other psychoactive substance abuse with psychoactive substance-induced psychotic disorder with delusions. A condition where someone abuses multiple drugs and develops false beliefs or delusions that are directly caused by the substance use. F19.150 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).

Under the CMS-HCC V28 risk adjustment model, F19.150 maps to Drug/Alcohol Psychosis (HCC 135) with a community, non-dual, aged base RAF weight of 0.000. Under the older V24 model, F19.150 mapped to the same category but with a base RAF weight of 0.434 — V28 recalibrated weights across the entire model. V28 is the CMS-HCC risk adjustment model that reached 100% phase-in for payment year 2026, replacing V24 which was used during the PY2024–PY2025 transition.

Document whether delusions are bizarre or non-bizarre in the clinical record. Because F19.150 maps to a payment HCC, the provider's documentation must satisfy MEAT criteria (Monitor, Evaluate, Assess, or Treat) for the encounter to count toward the patient's Medicare Advantage risk adjustment score. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.

HCC Buddy maintains structured V28 and V24 mapping, RAF weights, and MEAT documentation criteria for F19.150 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.

Coding Tips

  • Document whether delusions are bizarre or non-bizarre in the clinical record
  • Confirm the psychotic symptoms are substance-induced and not due to an independent psychotic disorder

Clinical Significance

This code captures substance-induced psychotic disorder, which represents a serious psychiatric complication of other psychoactive substance abuse. Substance-induced psychosis significantly increases healthcare utilization, emergency department visits, and hospitalization risk, making accurate capture critical for risk adjustment. These patients require intensive psychiatric management and close monitoring for progression to chronic psychotic disorders.

Documentation Requirements

  • Provider documentation specifying the psychoactive substance(s) involved (e.g., designer drugs, bath salts, kratom, polysubstance use)
  • Clinical documentation supporting substance abuse pattern (maladaptive use pattern causing clinically significant impairment) without meeting criteria for dependence
  • Documentation of fixed false beliefs (delusions) that developed during or shortly after substance use and are directly attributable to the substance
  • Assessment and plan addressing the substance use disorder with treatment approach documented

Commonly Confused Codes

  • F19.20-F19.29 (Other psychoactive substance dependence) — dependence indicates a more severe pattern with tolerance, compulsive use, or withdrawal; abuse is a less severe use pattern
  • F19.90-F19.99 (Other psychoactive substance use, unspecified) — unspecified use is used when abuse vs. dependence is not documented
  • F19.151 (Psychotic disorder with hallucinations) — hallucinations are false sensory perceptions; delusions are fixed false beliefs
  • F20-F29 (Schizophrenia spectrum disorders) — primary psychotic disorders are not substance-induced; confirm temporal relationship with substance use
  • F10-F16 (Specific substance codes: alcohol, opioids, cannabis, sedatives, cocaine, stimulants) — use substance-specific codes when the substance is identified; F19 is for 'other' or multiple unspecified substances

Code Hierarchy

Open F19.150 in the Interactive Encoder

See full code details, AI coding tips, HCC mappings, and related codes in our interactive encoder. Start your 14-day Pro trial — no credit card required.